The activation of adenosine monophosphate–activated protein kinase inhibits the migration of tongue squamous cell carcinoma cells by targeting Claudin‐1 via epithelial–mesenchymal transition
Animal Models and Experimental Medicine · 2024
DOI: 10.1002/ame2.12444 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, 2024. Verfasst von Xin-Yue Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Claudin-1, Tongue Neoplasms, Cell Movement. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanxi Basic Research Program of China, National Natural Science Foundation of China, Shanxi Bethune Hospital Talent Intruduction Research Start-up Fund of China.
Abstract (Originalsprache)
Background
The role of Claudin‐1 in tongue squamous cell carcinoma (TSCC) metastasis needs further clarification, particularly its impact on cell migration. Herein, our study aims to investigate the role of Claudin‐1 in TSCC cell migration and its underlying mechanisms.
Methods
36 TSCC tissue samples underwent immunohistochemical staining for Claudin‐1. Western blotting and immunofluorescence analyses were conducted to evaluate Claudin‐1 expression and distribution in TSCC cells. Claudin‐1 knockdown cell lines were established using short hairpin RNA transfection. Migration effects were assessed through wound healing assays. Furthermore, the expression of EMT‐associated molecules was measured via western blotting.
Results
Claudin‐1 expression decreased as TSCC malignancy increased. Adenosine monophosphate–activated protein kinase (AMPK) activation led to increased Claudin‐1 expression and membrane translocation, inhibiting TSCC cell migration and epithelial–mesenchymal transition (EMT). Conversely, Claudin‐1 knockdown reversed these inhibitory effects on migration and EMT caused by AMPK activation.
Conclusions
Our results indicated that AMPK activation suppresses TSCC cell migration by targeting Claudin‐1 and EMT pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medicine, Hubei University of Chinese Medicine, Wuhan, China.
- Hubei Shizhen Laboratory, Wuhan, Hubei, China.
- Sino-German Biomedical Center, Hubei University of Technology, Wuhan, China.
- Center of Applied Biotechnology, Wuhan Institute of Bioengineering, Wuhan, China.
- Department of Stomatology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
- Department of Oral and Maxillofacial Surgery, Shanxi Provincial People's Hospital, Taiyuan, China.
ORCID-Profile: Xin-Yue Zhou, Yu Wang
Förderung
- Shanxi Basic Research Program of China
- National Natural Science Foundation of China
- Shanxi Bethune Hospital Talent Intruduction Research Start-up Fund of China
Zitieren
APA
Zhou, X. Y., Liu, Q. M., Li, Z., Liu, X. Y., Zhao, Q. W., Wang, Y., Wu, F. H., Zhao, G., Sun, R., & Guo, X. H. (2024). The activation of adenosine monophosphate–activated protein kinase inhibits the migration of tongue squamous cell carcinoma cells by targeting Claudin‐1 via epithelial–mesenchymal transition. Animal Models and Experimental Medicine. https://doi.org/10.1002/ame2.12444
Vancouver
Zhou XY, Liu QM, Li Z, Liu XY, Zhao QW, Wang Y, et al. The activation of adenosine monophosphate–activated protein kinase inhibits the migration of tongue squamous cell carcinoma cells by targeting Claudin‐1 via epithelial–mesenchymal transition. Animal Models and Experimental Medicine. 2024. doi:10.1002/ame2.12444
BibTeX
@article{Zhou2024,
author = {Zhou, Xin-Yue and Liu, Qiu-Ming and Li, Zhuang and Liu, Xia-Yang and Zhao, Qi-Wei and Wang, Yu and Wu, Feng-Hua and Zhao, Gang and Sun, Rui and Guo, Xiao-Hong},
title = {The activation of adenosine monophosphate–activated protein kinase inhibits the migration of tongue squamous cell carcinoma cells by targeting Claudin‐1 via epithelial–mesenchymal transition},
journal = {Animal Models and Experimental Medicine},
year = {2024},
doi = {10.1002/ame2.12444}
}
EUVIMED